Results 271 to 280 of about 3,122,357 (335)

Rationale and design of the randomized ‘early ventricular assist device’—Trial (VAD‐DZHK3)

ESC Heart Failure, EarlyView.
The VAD‐DZHK3 trial is a randomised controlled study evaluating whether elective LVAD implantation improves outcomes in end‐stage heart failure (HF) patients listed for heart transplantation compared with delayed implantation after clinical deterioration.
Christoph Knosalla, Gloria Färber, Andreas J. Rieth, Rolf Wachter, Marius Placzek, Wolfgang Albert, Gerd Hasenfuß, Volkmar Falk, Tim Friede, for the VAD‐DZHK3 Investigators   +9 more
wiley   +1 more source

Pregnancy complications and new-onset maternal autoimmune disease. [PDF]

Int J Epidemiol
Scime NV, Grandi SM, Ray JG, Dennis CL, De Vera MA, Banack HR, Vigod SN, Boblitz A, Brown HK.   +8 more
europepmc   +1 more source

The role of intra‐abdominal pressure and point of care ultrasound to guide decongestive therapies in acute heart failure

ESC Heart Failure, EarlyView.
The ABDOPOCUS‐HF trial is a randomized, single‐blind, low‐intervention clinical trial (n = 168) investigating the utility of intra‐abdominal pressure (IAP) and point of care ultrasound to guide decongestive therapies during the first 72 hours after admission for acute heart failure.
C. Josa‐Laorden, A. Campos‐Saenz de Santamaría, S. Crespo‐Aznarez, J. Pérez‐Silvestre, E. Montero‐Hernandez, P. Llacer‐Iborra, J. Torres‐Macho, M. Méndez‐Bailon, J.L. Morales‐Rull, P. Salamanca‐Bautista, N. Fernández‐Villa, I. Torres‐Courchoud, M.A. Vázquez‐Ronda, R. Martínez‐Gutiérrez, P. Serrano‐Irigoyen, N. García‐Lorente, J.C. Trullas, M. Cobo‐Marcos, M.J. Pinilla, M. Sánchez‐Marteles, J. Rubio‐Gracia   +20 more
wiley   +1 more source

Relationship Between Improvements in Glycemic Control and Risk of Pregnancy Complications in Patients With Diabetes Mellitus: Metaregression Analysis of Randomized Controlled Trials of Intensive Glucose Management. [PDF]

J Diabetes Res
Kodama S, Fujihara K, Yagyuuda N, Yachi Y, Horikawa C, Takeda Y, Morikawa SY, Yamada T, Kato K, Nakagawa Y, Tanaka S, Shimano H, Sone H.   +12 more
europepmc   +1 more source

Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study

European Journal of Heart Failure, EarlyView.
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan, Oliver I. Brown, Michael Drozd, Andrew M.N. Walker, Marilena Giannoudi, Sam Straw, Maria F. Paton, John Gierula, Melanie McGinlay, Kathryn J. Griffin, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon   +12 more
wiley   +1 more source

The Camden Study-A Pregnancy Cohort Study of Pregnancy Complications and Birth Outcomes in Camden, New Jersey, USA. [PDF]

Nutrients
Shiau S, Chen X, April-Sanders A, Francis EC, Rawal S, Hansel M, Adeyemi K, Rivera-Núñez Z, Barrett ES.   +8 more
europepmc   +1 more source

Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt, Wilfried Mullens, Christophe Leclercq, Andrea M. Russo, Gianluigi Savarese, Michael Böhm, Loreena Hill, Koichiro Kinugawa, Naoki Sato, William T. Abraham, Antoni Bayes‐Genis, Alexandre Mebazaa, Giuseppe M.C. Rosano, Shelley Zieroth, Cecilia Linde, Javed Butler   +15 more
wiley   +1 more source

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review

European Journal of Heart Failure, EarlyView.
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo, Wenbin Xiao, Yusuf Z. Sener, Wouter C. Meijers, Robert M.A. van der Boon, Elfatih A. Hasabo, Osama Soliman, Rudolf A. de Boer, Kadir Caliskan   +8 more
wiley   +1 more source

Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
Abstract Obesity and heart failure (HF) represent two growing pandemics. In the general population, obesity affects one in eight adults and is linked with an increased risk for HF. Obesity is even more common in patients with HF, where it complicates the diagnosis of HF and is linked with worse symptoms and impaired exercise capacity. Over the past few
Gianluigi Savarese, Gabriele G. Schiattarella, Felix Lindberg, Markus S. Anker, Antoni Bayes‐Genis, Magnus Bäck, Frieder Braunschweig, Chiara Bucciarelli‐Ducci, Javed Butler, Antonio Cannata, Federico Capone, Ovidiu Chioncel, Emilia D'Elia, Arantxa González, Gerasimos Filippatos, Nicolas Girerd, Jean‐Sébastien Hulot, Carolyn S.P. Lam, Lars H. Lund, Christoph Maack, Brenda Moura, Mark C. Petrie, Massimo Piepoli, Abdullah Shehab, Mehmet B. Yilmaz, Peter Seferovic, Carlo G. Tocchetti, Giuseppe M.C. Rosano, Marco Metra   +28 more
wiley   +1 more source

A survey of obstetric complications and pregnancy outcomes in paediatric and nonpaediatric anaesthesiologists [PDF]

, 2003
Virginia T. Gauger, Terri Voepel‐Lewis, Philip Rubin, Amy Kostrzewa, Alan R. Tait   +4 more
openalex